Skip to main content

MoneyWorks4Me

The sales is pegged at Rs. 94.13 millions for the June 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 99.37 millions during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -18.83 millions as compared to Net Profit of Rs. 16.01 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -16.15% as compared to 17.00% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 94.13 99.37 -5.27 94.13 99.37 -5.27 401.34 251.78 59.40
Other Income 0.67 0.68 -1.47 0.67 0.68 -1.47 3.06 8.02 -61.85
PBIDT -16.15 17.00 -195.00 -16.15 17.00 -195.00 14.24 -19.66 -172.43
Interest 1.99 0.47 323.40 1.99 0.47 323.40 4.01 3.89 3.08
PBDT -18.14 16.53 -209.74 -18.14 16.53 -209.74 10.23 -23.55 -143.44
Depreciation 0.69 0.52 32.69 0.69 0.52 32.69 2.76 1.76 56.82
PBT -18.83 16.01 -217.61 -18.83 16.01 -217.61 7.47 -25.31 -129.51
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -1.26 -0.11 1045.45
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.26 -0.11 1045.45
PAT -18.83 16.01 -217.61 -18.83 16.01 -217.61 8.73 -25.20 -134.64
Equity 74.20 74.20 0.00 74.20 74.20 0.00 74.20 74.20 0.00
PBIDTM(%) -17.16 17.11 -200.29 -17.16 17.11 -200.29 3.55 -7.81 -145.44
Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..